2014 CRO Leadership Awards Winner
Categories Won:
-
Quality
-
Reliability
-
Regulatory
-
Productivity
-
Innovation
Drug Life Cycle Stages:
- Research & Development – Preclinical, and Clinical (Phase 1, Phase 2, and Phase 3)
- Drug Substance Production – Primary Process Development, Drug Substance Production
- Formulated Drug Production – Dosage Form Development, Dosage Form Production, Packaging
Main Service Areas:
Bioanalytical, Clinical, Preclinical, CMC Analytical
Services & Capabilities:
Comprehensive analytical support for large and small molecules, pre-formulation through commercial release: MD/MV; development & commercial stability; extractables & leachables; release testing; metabolite/impurity isolation, ID and characterization; bioanalysis; DMPK; plus niche expertise in radiolabeling synthesis and environmental assessments
Therapeutic Areas:
All therapeutic areas, including those involving high potency and cytotoxic drugs.
John Bucksathpresident and CEO“It is an honor to be recognized for the 2014 CRO Leadership Award by our clients. It is validating to see our investments in expertise, talent, and leadership, combined with a strong foundation in quality, service, and capacity, are coming together. Our mission is to be a trusted extension of our client’s development team.” |